Intense pulsed light in the treatment of telangiectasias: Case report of Behçet's disease with superficial vascular involvement

References

• McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297.
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284–1291.
   PubMed Web of Science ®Google Scholar
• Marshall SE. Behçet's disease. Best Pract Res Clin Rheumatol. 2004;18:291–311.
   PubMed Web of Science ®Google Scholar
• Yazici Y, Yurdakul S, Yazici H. Behçet's syndrome. Curr Rheumatol Rep. 2010;12:429–435. doi:10.1007/s11926-010-0132-z
   PubMedGoogle Scholar
• [No authors listed]. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet. 1990;335:1078–1080.
   PubMed Web of Science ®Google Scholar
• Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet,s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54: 213–220.
   PubMedGoogle Scholar
• Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982;100:1455–1458.
   PubMed Web of Science ®Google Scholar
• Verity DH, Wallace GR, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens. 1999;54:264–272.
   PubMed Web of Science ®Google Scholar
• Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, Jiménez Hernández C, Riebeling-Navarro C, Nava Zavala A, et al. Etiopathogenesis of Behcet's disease. Autoimmun Rev. 2010;9:241–245. doi:10.1016/j.autrev.2009.10.005. Epub 2009 Oct 30.
   PubMed Web of Science ®Google Scholar
• Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behçet's disease. Autoimmun Rev. 2012;11:687–698. doi:10.1016/j.autrev.2011.11.026. Epub 2011 Dec 11.
   PubMed Web of Science ®Google Scholar
• Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol. 1997;14:21–32.
   PubMedGoogle Scholar
• Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet. 1996;347: 789–794.
   PubMed Web of Science ®Google Scholar
• Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J Allergy Clin Immunol. 2011;128:655–664. doi:10.1016/j.jaci.2011.05.029. Epub 2011 Jul 2.
   PubMed Web of Science ®Google Scholar
• Kontogiannis V, Powell RJ. Behçet's disease. Postgrad Med J. 2000;76:629–637.
   PubMedGoogle Scholar
• Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P. Mortality in Behçet's disease. Arthritis Rheum. 2010;62:2806–2812. doi:10.1002/art.27568.
   PubMed Web of Science ®Google Scholar
• Kerkeni N, Zaraa I, Ayachi J, El Euch D, Mokni M, Ben Osman A. Behçet's disease: a profile of mucocutaneous features. Acta Dermatovenerol Alp Panonica Adriat. 2010; 19:11–15.
   PubMedGoogle Scholar
• Tohmé A, Aoun N, El-Rassi B, Ghayad E. Vascular manifestations of Behçet's disease. Eighteen cases among 140 patients. Joint Bone Spine. 2003;70:384–389.
   PubMed Web of Science ®Google Scholar
• Ames PR, Steuer A, Pap A, Denman AM. Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford). 2001;40:652–655.
   PubMed Web of Science ®Google Scholar
• Sekkach Y, Elomri N, Jira M, Elqatni M, Fatihi J, Mekouar F, et al. [Behcet syndrome: thirty comments with lung and vascular injury of peripheral vessels]. Presse Med. 2012;41:e52–62. doi:10.1016/j.lpm.2011.05.018. Epub 2011 Aug 24.
   Google Scholar
• Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. Clin Exp Rheumatol. 2011;29:S47–53. Epub 2011 Sep 27.
   PubMed Web of Science ®Google Scholar
• Saadoun D, Asli B, Wechsler B, Houman H, Geri G, Desseaux K, et al. Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine (Baltimore). 2012;91:18–24. doi:10.1097/MD.0b013e3182428126.
   PubMed Web of Science ®Google Scholar
• Hamuryudan V, Er T, Seyahi E, Akman C, Tüzün H, Fresko I, et al. Pulmonary artery aneurysms in Behçet syndrome. Am J Med. 2004;117:867–870.
   PubMed Web of Science ®Google Scholar
• Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet's disease: an update. Curr Opin Rheumatol. 2011;23:24–31. doi:10.1097/BOR.0b013e3283410088.
   PubMed Web of Science ®Google Scholar
• Düzgün N, Ateş A, Aydintuğ OT, Demir O, Olmez U. Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol. 2006;35:65–68.
   PubMed Web of Science ®Google Scholar
• Wechsler B, Du LT, Kieffer E.. [Cardiovascular manifestations of Behçet's disease]. Ann Med Interne (Paris). 1999;150: 542–554.
   PubMedGoogle Scholar
• Ko GY, Byun JY, Choi BG, Cho SH. The vascular manifestations of Behçet's disease: angiographic and CT findings. Br J Radiol. 2000;73:1270–1274.
   PubMedGoogle Scholar
• Skiveren J, Mikkelsen MR, Daugbjerg H, Wulf HC. Skin reactions and quality of life after x-ray therapy of Basal cell carcinoma. J Skin Cancer. 2012;2012:825095. doi:10.1155/ 2012/825095. Epub 2012 Dec 20.
   PubMedGoogle Scholar
• Cribier B. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Ann Dermatol Venereol. 2011;138 Suppl 3: S184–191. doi:10.1016/S0151-9638(11)70088-6.
   Google Scholar
• Halachmi S, Gabari O, Cohen S, Koren R, Amitai DB, Lapidoth M. Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment. Lasers Med Sci. 2013 Mar 14. [Epub ahead of print].
   Google Scholar
• Guinovart RM, Vicente A, Rovira C, Suñol M, González-Enseñat MA. Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus. Lupus. 2012; 21:552–555. doi:10.1177/0961203311430701. Epub 2011 Dec 14.
   PubMedGoogle Scholar
• Shipman AR, Millington GW. Obesity and the skin. Br J Dermatol. 2011;165:743–750. doi:10.1111/j.1365-2133.2011.10393.x.
   PubMed Web of Science ®Google Scholar
• Har-Shai Y, Barak A, Taran A, Weissman A. Striae distensae of augmented breasts after oral contraceptive therapy. Ann Plast Surg. 1999;42:193–195.
   PubMedGoogle Scholar
• Cordeiro RC, Zecchin KG, de Moraes AM. Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae. Int J Dermatol. 2010;49:30–32. doi:10.1111/j.1365-4632.2008.04005.x.
   PubMed Web of Science ®Google Scholar
• Guimarães PA, Haddad A, Sabino Neto M, Lage FC, Ferreira LM. Striae distensae after breast augmentation: treatment using the nonablative fractionated 1550-nm erbium glass laser. Plast Reconstr Surg. 2013;131:636–642. doi:10.1097/PRS.0b013e31827c7010.
   PubMed Web of Science ®Google Scholar
• Savas JA, Ledon JA, Franca K, Nouri K. Lasers and lights for the treatment of striae distensae. Lasers Med Sci. 2013 May 7 [Epub ahead of print].
   Google Scholar
• Adrian RM, Tanghetti EA. Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg. 1998;24:71–74.
   PubMedGoogle Scholar
• Goldberg DJ, Meine JG. A comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases. Dermatol Surg. 1999;25:463–467.
   PubMedGoogle Scholar
• Eremia S, Li CY. Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd:YAG laser–a prospective study of 47 patients. J Cosmet Laser Ther. 2001;3:147–153.
   PubMedGoogle Scholar
• Groot D, Rao J, Johnston P, Nakatsui T. Algorithm for using a long-pulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg. 2003;29:35–42.
   PubMedGoogle Scholar
• Jiménez GP, Flores F, Berman B, Gunja-Smith Z. Treatment of striae rubra and striae alba with the 585-nm pulsed-dye laser. Dermatol Surg. 2003;29:362–365.
   PubMed Web of Science ®Google Scholar
• Clementoni MT, Gilardino P, Muti GF, Signorini M, Pistorale A, Morselli PG, Cavina C. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37:9–13.
   PubMedGoogle Scholar
• Bjerring P, Christiansen K, Troilius A, Dierickx C. Facial photo rejuvenation using two different intense pulsed light (IPL) wavelength bands. Lasers Surg Med. 2004;34:120–126.
   PubMed Web of Science ®Google Scholar
• Tanzi EL, Lupton JR, Alster TS. Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 2003;49:1–31.
   PubMed Web of Science ®Google Scholar
• Srinivas CR, Kumaresan M. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77:349–368.
   PubMed Web of Science ®Google Scholar
• Rothfleisch JE, Kosmann MK, Levine VJ, Ashinoff R. Laser treatment of congenital and acquired vascular lesions: update on lasers: a review. Dermatol Clin. 2002;20:1–18.
   PubMedGoogle Scholar